Azalea Health Version 2.1 ONC Drummond Certified – 2014 Edition Complete Information

Drummond certification complete EHR ambulatoryAzalea Health’s Azalea EHR version 2.1 was 2014 Stage 2 certified under Drummond Group’s Electronic Health Records Office of the National Coordinator Authorized Certification Body (ONC-ACB) program on 10/08/2015.

Drummond Group’s ONC-ACB certification program certifies that EHRs meet the meaningful use criteria for either eligible provider or hospital technology. In turn, healthcare providers using the EHR systems of certified vendors are qualified to receive federal stimulus monies upon demonstrating meaningful use of the technology.

Because the Azalea solution is cloud-based and compliant, our customers don’t have to worry about upgrading to a new version.

Unique certification number:

CHPL ID: 10082015-3440-5

Criteria to which Azalea EHR is certified:

170.314(a)(1)  COMPUTERIZED PROVIDER ORDER ENTRY
170.314(a)(3)  DEMOGRAPHICS
170.314(a)(5)  PROBLEM LIST
170.314(a)(6)  MEDICATION LIST
170.314(a)(7)  MEDICATION ALLERGY LIST
170.314(a)(8)  CLINICAL DECISION SUPPORT
170.314(b)(1)  TRANSITIONS OF CARE – RECEIVE, DISPLAY, AND INCORPORATE TRANSITION OF CARE/REFERRAL SUMMARIES
170.314(b)(2)  TRANSITIONS OF CARE – CREATE AND TRANSMIT TRANSITION OF CARE/REFERRAL SUMMARIES
170.314(b)(7)  DATA PORTABILITY
170.314(c)(1)  CLINICAL QUALITY MEASURES – CAPTURE AND EXPORT
170.314(c)(2)  CLINICAL QUALITY MEASURES – IMPORT AND CALCULATE
170.314(c)(3)  CLINICAL QUALITY MEASURES – ELECTRONIC SUBMISSION
170.314(d)(1)  AUTHENTICATION, ACCESS CONTROL, AND AUTHORIZATION
170.314(d)(2)  AUDITABLE EVENTS AND TAMPER-RESISTANCE
170.314(d)(3)  AUDIT REPORT(S)
170.314(d)(4)  AMENDMENTS
170.314(d)(5)  AUTOMATIC LOG-OFF
170.314(d)(6)  EMERGENCY ACCESS
170.314(d)(7)  END-USER DEVICE ENCRYPTION
170.314(d)(8)  INTEGRITY
170.314(g)(4)  QUALITY MANAGEMENT SYSTEM
Clinical Quality Measures to which Azalea EHR is certified:
CMS2  PREVENTIVE CARE AND SCREENING: SCREENING FOR CLINICAL DEPRESSION AND FOLLOW-UP PLAN
CMS22  PREVENTIVE CARE AND SCREENING: SCREENING FOR HIGH BLOOD PRESSURE AND FOLLOW-UP DOCUMENTED
CMS50  CLOSING THE REFERRAL LOOP: RECEIPT OF SPECIALIST REPORT
CMS52  HIV/AIDS: PNEUMOCYSTIS JIROVECI PNEUMONIA (PCP) PROPHYLAXIS
CMS56  FUNCTIONAL STATUS ASSESSMENT FOR HIP REPLACEMENT
CMS61  PREVENTIVE CARE AND SCREENING: CHOLESTEROL – FASTING LOW DENSITY LIPOPROTEIN (LDL-C) TEST PERFORMED
CMS62  HIV/AIDS: MEDICAL VISIT
CMS64  PREVENTIVE CARE AND SCREENING: RISK- STRATIFIED CHOLESTEROL – FASTING LOW DENSITY LIPOPROTEIN (LDL-C)
CMS65  HYPERTENSION: IMPROVEMENT IN BLOOD PRESSURE
CMS66  FUNCTIONAL STATUS ASSESSMENT FOR KNEE REPLACEMENT
CMS68  DOCUMENTATION OF CURRENT MEDICATIONS IN THE MEDICAL RECORD
CMS69  PREVENTIVE CARE AND SCREENING: BODY MASS INDEX (BMI) SCREENING AND FOLLOW-UP
CMS74  PRIMARY CARIES PREVENTION INTERVENTION AS OFFERED BY PRIMARY CARE PROVIDERS, INCLUDING DENTISTS
CMS75  CHILDREN WHO HAVE DENTAL DECAY OR CAVITIES
CMS77  HIV/AIDS: RNA CONTROL FOR PATIENTS WITH HIV
CMS82  MATERNAL DEPRESSION SCREENING
CMS90  FUNCTIONAL STATUS ASSESSMENT FOR COMPLEX CHRONIC CONDITIONS
CMS117  CHILDHOOD IMMUNIZATION STATUS
CMS122  DIABETES: HEMOGLOBIN A1C POOR CONTROL
CMS123  DIABETES: FOOT EXAM
CMS124  CERVICAL CANCER SCREENING
CMS125  BREAST CANCER SCREENING
CMS126  USE OF APPROPRIATE MEDICATIONS FOR ASTHMA
 CMS127 Met
CMS127  PNEUMONIA VACCINATION STATUS FOR OLDER ADULTS
CMS128  ANTI-DEPRESSANT MEDICATION MANAGEMENT
CMS129  PROSTATE CANCER: AVOIDANCE OF OVERUSE OF BONE SCAN FOR STAGING LOW RISK PROSTATE CANCER PATIENTS
CMS130  COLORECTAL CANCER SCREENING
CMS131  DIABETES: EYE EXAM
CMS132  CATARACTS: COMPLICATIONS WITHIN 30 DAYS FOLLOWING CATARACT SURGERY REQUIRING ADDITIONAL SURGICAL PROCEDURES
CMS133  CATARACTS: 20/40 OR BETTER VISUAL ACUITY WITHIN 90 DAYS FOLLOWING CATARACT SURGERY
CMS134  DIABETES: URINE PROTEIN SCREENING
CMS135  HEART FAILURE (HF): ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITOR OR ANGIOTENSIN RECEPTOR BLOCKER (ARB) THERAPY FOR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)
CMS136  ADHD: FOLLOW-UP CARE FOR CHILDREN PRESCRIBED ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) MEDICATION
CMS137  INITIATION AND ENGAGEMENT OF ALCOHOL AND OTHER DRUG DEPENDENCE TREATMENT
CMS138  PREVENTIVE CARE AND SCREENING: TOBACCO USE: SCREENING AND CESSATION INTERVENTION
CMS139  SCREENING FOR FUTURE FALL RISK
CMS140  BREAST CANCER: HORMONAL THERAPY FOR STAGE IC-IIIC ESTROGEN RECEPTOR/PROGESTERONE RECEPTOR (ER/PR) POSITIVE BREAST CANCER
CMS141  COLON CANCER: CHEMOTHERAPY FOR AJCC STAGE III COLON CANCER PATIENTS
CMS142  DIABETIC RETINOPATHY: COMMUNICATION WITH THE PHYSICIAN MANAGING ONGOING DIABETES CARE
CMS143  PRIMARY OPEN ANGLE GLAUCOMA (POAG): OPTIC NERVE EVALUATION
CMS144  HEART FAILURE (HF): BETA-BLOCKER THERAPY FOR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD)
CMS145  CORONARY ARTERY DISEASE (CAD): BETA-BLOCKER THERAPY- PRIOR MYOCARDIAL INFARCTION (MI) OR LEFT VENTRICULAR SYSTOLIC DYSFUNCTION (LVEF <40%)
CMS146  APPROPRIATE TESTING FOR CHILDREN WITH PHARYNGITIS
CMS147  PREVENTATIVE CARE AND SCREENING: INFLUENZA IMMUNIZATION
CMS148  HEMOGLOBIN A1C TEST FOR PEDIATRIC PATIENTS
CMS149  DEMENTIA: COGNITIVE ASSESSMENT
CMS153  CHLAMYDIA SCREENING FOR WOMEN
CMS154  APPROPRIATE TREATMENT FOR CHILDREN WITH UPPER RESPIRATORY INFECTION (URI)
CMS155  WEIGHT ASSESSMENT AND COUNSELING FOR NUTRITION AND PHYSICAL ACTIVITY FOR CHILDREN AND ADOLESCENTS
CMS156  USE OF HIGH-RISK MEDICATIONS IN THE ELDERLY
CMS157  ONCOLOGY: MEDICAL AND RADIATION – PAIN INTENSITY QUANTIFIED
CMS158  PREGNANT WOMEN THAT HAD HBSAG TESTING
CMS159  DEPRESSION REMISSION AT TWELVE MONTHS
CMS160  DEPRESSION UTILIZATION OF THE PHQ-9 TOOL
CMS161  MAJOR DEPRESSIVE DISORDER (MDD): SUICIDE RISK ASSESSMENT
CMS163  DIABETES: LOW DENSITY LIPOPROTEIN (LDL) MANAGEMENT
 CMS164 Met
CMS164  ISCHEMIC VASCULAR DISEASE (IVD): USE OF ASPIRIN OR ANOTHER ANTITHROMBOTIC
CMS165  CONTROLLING HIGH BLOOD PRESSURE
CMS166  USE OF IMAGING STUDIES FOR LOW BACK PAIN
CMS167  DIABETIC RETINOPATHY: DOCUMENTATION OF PRESENCE OR ABSENCE OF MACULAR EDEMA AND LEVEL OF SEVERITY OF RETINOPATHY
CMS169  BIPOLAR DISORDER AND MAJOR DEPRESSION: APPRAISAL FOR ALCOHOL OR CHEMICAL SUBSTANCE USE
CMS177  CHILD AND ADOLESCENT MAJOR DEPRESSIVE DISORDER: SUICIDE RISK ASSESSMENT
CMS179  ADE PREVENTION AND MONITORING: WARFARIN TIME IN THERAPEUTIC RANGE.
CMS182  ISCHEMIC VASCULAR DISEASE (IVD): COMPLETE LIPID PANEL AND LDL CONTROL
CQM Domains to with Azalea EHR has been certified:
Care Coordination
Efficient Use of Healthcare Resources  
Patient Safety
Clinical Process/Effectiveness  
Population/Public Health  
Patient & Family Engagement  


Additional software use demonstrate compliance with certification criteria
:

Dr. First
Phimail

ONC Disclaimer:

This Complete EHR is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services.  


Cost and Limitations:

Cost and Limitations table for meaningful use page on website